Table 2.
Association of aldolaseC IHC with clinicopathologic variables
| Negative |
Positive |
p Value | |
|---|---|---|---|
| Variables | (n=59) | (n=220) | |
| Age (median) | 69 | 65 | 0.4* |
| Myometrial invasion (median) | 21 | 31.5 | 0.0438 |
| Stage | |||
| I | 41 (69.49) | 140 (63.64) | 0.7656 |
| II | 8 (13.56) | 27 (12.27) | |
| III | 7 (11.86) | 36 (16.36) | |
| IV | 3 (5.08) | 17 (7.73) | |
| Tumour size (cm) | |||
| ≤2 | 15 (25.42) | 47 (21.36) | 0.4866** |
| >2 | 44 (74.58) | 173 (78.64) | |
| LVI | |||
| No | 46 (77.97) | 156 (70.91) | 0.3273 |
| Yes | 13 (22.03) | 64 (29.09) | |
| Grade_FIGO | |||
| 1 | 24 (40.68) | 95 (43.18) | 0.9266 |
| 2 | 11 (18.64) | 42 (19.09) | |
| 3 | 24 (40.68) | 83 (37.73) | |
| Grade_nuclear | |||
| 1 | 15 (25.42) | 78 (35.45) | 0.3096 |
| 2 | 19 (32.2) | 56 (25.45) | |
| 3 | 25 (42.37) | 86 (39.09) | |
| Lymph node status | |||
| Positive | 6 (16.22) | 44 (29.73) | 0.1461 |
| Negative | 31 (83.78) | 104 (70.27) | |
| Subtype | |||
| CCC+Serous | 17 (28.81) | 60 (27.27) | 0.87 |
| Endometrioid | 42 (71.19) | 160 (72.73) | |
| Recurrence | |||
| No | 45 (81.82) | 170 (82.13) | 1 |
| Yes | 10 (18.18) | 37 (17.87) | |
| Status | |||
| ANED | 41 (69.49) | 147 (66.82) | 0.7561 |
| Others | 18 (30.51) | 73 (33.18) | |
*p Value calculated by logistic linear regression.
**p Value calculated by Fisher's exact test.
ANED, alive with no evidence of disease; FIGO, International Federation of Gynecology and Obstetrics; IHC, immunohistochemical; LVI, lymphovascular invasion.